First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study

Phase Ii ◽

Randomized Study ◽

Metastatic Breast ◽

First Line

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

Medical Oncology ◽

10.1007/s12032-010-9754-2 ◽

2010 ◽

Vol 28 (S1) ◽

pp. 142-151 ◽

Cited By ~ 3

Author(s):

M. Ghosn ◽

P. Aftimos ◽

F. S. Farhat ◽

J. G. Kattan ◽

C. Hanna ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Randomized Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Weekly Docetaxel ◽

Her 2 ◽

Phase II, two-arm, double-blind, multicenter, randomized study of the combination of oral WX-671 plus capecitabine versus capecitabine in first-line HER2-negative metastatic breast cancer (MBC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps131 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS131-TPS131 ◽

Cited By ~ 2

Author(s):

L. J. Goldstein ◽

S. M. Stemmer ◽

B. Schmalfeldt ◽

N. Gottschalk ◽

F. Cardoso ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Randomized Study ◽

Metastatic Breast ◽

First Line ◽

Double Blind

Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3238-6 ◽

2014 ◽

Vol 149 (1) ◽

pp. 171-179 ◽

Cited By ~ 43

Author(s):

Michael R. Clemens ◽

Oleg A. Gladkov ◽

Elaina Gartner ◽

Vladimir Vladimirov ◽

John Crown ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Randomized Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Open Label ◽

277 ORAL Interim results of a phase II randomized study of lapatinib (GW572016) as first-line treatment for patients with FISH-amplified advanced or metastatic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80575-0 ◽

2005 ◽

Vol 3 (2) ◽

pp. 78 ◽

Cited By ~ 3

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Randomized Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy

First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial

Medical Journal of Indonesia ◽

10.13181/mji.v14i1.166 ◽

2005 ◽

pp. 20

Author(s):

Abdulmuthalib Abdulmuthalib ◽

Idral Darwis ◽

Nugroho Prayogo ◽

Sutjipto Sutjipto

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Line Chemotherapy

A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer

Oncology ◽

10.1159/000097945 ◽

2006 ◽

Vol 70 (5) ◽

pp. 330-338 ◽

Cited By ~ 2

Author(s):

Ali I. Shamseddine ◽

Zaher K. Otrock ◽

Mohamad J. Khalifeh ◽

Hanan R. Yassine ◽

Maya Charafeddine ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Clinical Phase ◽

Sequential Combination ◽

5002 MoniCa: A multicenter phase II study to determine the efficacy of capecitabine as first line monochemotherapy in patients with HER2 negative, medium-risk, metastatic breast cancer (GBG39)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70894-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 260 ◽

Cited By ~ 2

Author(s):

M. Kaufmann ◽

M.W. Sütterlin ◽

I. Schrader ◽

B. Gerber ◽

W. Bauer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Multicenter Phase ◽

Medium Risk ◽

Negative Medium

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy